This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Gfb (Abc), LLC. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Thomas E. Stumpfig and His Pharmaceutical Formulation Patent.
Introduction
Thomas E. Stumpfig is an inventor associated with Bend, Oregon. His patent work includes a spray-dried formulation of a pyridazinone TRPC5 inhibitor, a pharmaceutical innovation intended for use in solid dosage forms.
Latest Patents
Stumpfig is credited with 1 patent: “Spray-dried formulation of a pyridazinone TRPC5 inhibitor.” The patent describes spray-dried formulations of the compound, methods and compositions for preparing them, and solid dosage forms containing them. The disclosed dosage forms are intended for potential use in treating kidney diseases, neuropathies associated with diseases or conditions, pain, anxiety, and depression.
Career Highlights
The supplied information associates Stumpfig with Gfb (Abc), LLC. His patent focuses on pharmaceutical formulation and the development of dosage forms containing a TRPC5 inhibitor.
Collaborations
The patent information identifies Daniel T. Smithey and Erica B. Schlesinger as Stumpfig’s coworkers.
Conclusion
Thomas E. Stumpfig’s recorded patent contribution concerns a spray-dried pharmaceutical formulation with potential applications in treating kidney diseases, neuropathies, pain, anxiety, and depression.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile